Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE: Low-Dose vs Standard-Dose Indomethacin for Post-ERCP Pancreatitis
NCT07088757Phase 4Recruiting
- Sponsor
- Changhai Hospital
- Start
- Sep 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Changhai Hospital. Started Sep 2025; status: recruiting.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT07088757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07088757.